카바페넴 기반 항생제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00027228
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

카바페넴계 항생제 시장 규모는 2021년 39억6457만달러에서 2028년 53억4662만달러로 성장할 것으로 예상된다. 2021~2028년 동안 CAGR 4.4%로 성장할 것으로 추정됩니다.

카바페넴은 더 넓은 항균 활성을 갖는 비정형 β-락탐 항생제의 일종입니다. 카바페넴 기반 항생제는 많은 그람 양성, 그람 음성 호기성 및 혐기성 박테리아를 다룰 수 있습니다. 또한, 카바페넴 기반 항생제는 대부분의 β-락타마제에 안정적입니다. 따라서 호중구감소성 감염, 복강내 감염 등 다양한 심각한 질환에 대한 경험적 단독요법으로 처방됩니다.

전략적 통찰력


유병률 증가 그람 음성균 감염의 증가와 제네릭 의약품의 생산 증가는 카바페넴 기반 항생제 시장의 성장을 촉진합니다. 그러나 지루하고 비용이 많이 드는 항생제 개발 과정으로 인해 시장 성장이 제한됩니다.

글로벌 카바페넴 기반 항생제 시장

< p>

시장 통찰력
그람 음성 세균 감염의 확산 증가

요로 감염과 같은 그람 음성 세균 감염 (UTI), 폐렴, 혈류 감염, 상처 또는 수술 부위 감염 및 수막염은 일반적으로 환자가 입원하는 동안 획득됩니다. 이러한 감염은 일반적으로 병원 획득 감염(HAI)으로 알려져 있습니다. UTI 및 폐렴과 같은 감염은 중환자실에 입원한 환자에게 흔히 발생합니다. 미국 국립 의료 안전 네트워크(National Healthcare Safety Network)에 따르면 HAI의 30%는 그람 음성균에 의해 발생하고, ~45%는 UTI, ~47%는 인공호흡기 관련 폐렴(VAP)에 의해 발생합니다. 그람 음성균에 의한 전염병의 유병률이 급속히 증가하고 있습니다.

또한 그람 음성균 감염은 여러 약물에 내성이 있으며 현재 이용 가능한 약물에 대한 더 나은 내성을 갖게 되었습니다. 항생제. 항생제 내성(AMR)은 현대 의학에 대한 세계적인 위협이 되었습니다. 따라서 임상 분리주에 대한 새로운 추세에 대한 지속적인 모니터링이 필요합니다. 유럽 라트비아의 연구자 그룹은 다양한 그람 음성 박테리아에 대한 AMR의 진행을 연구했습니다. 이들이 2021년 6월 MDPI 저널에 발표한 연구논문에 따르면 메로페넴, 에르타페넴 등 카바페넴계 항생제는 그람음성균에 대해 각각 3%, 5.4%의 내성률을 보이며 가장 효과적인 것으로 나타났다. 이 항생제는 그람 음성균의 치료제로 세계적으로 인정받고 있습니다. 따라서 카바페넴 기반 항생제에 대한 높은 수요는 앞으로도 계속될 것으로 추정됩니다.

질병통제예방센터(CDC)에 따르면 , 코로나19 팬데믹으로 인해 2020년 HAI 사례가 증가했습니다. 병원 입원이 전 세계적으로 증가하여 코로나19 환자의 2차 감염인 VAP 위험이 증가했습니다. 이로 인해 카바페넴 기반 항생제에 대한 수요가 증가했으며 이는 시장에 크게 도움이 되고 있습니다.

유형 기반 통찰력

카바페넴 기반 항생제 항생제 시장은 유형별로 메로페넴, 도리페넴, 이미페넴, 테비페넴 등으로 분류됩니다. 기타 부문은 2021년 카바페넴 기반 항생제 시장에서 가장 큰 점유율을 차지했으며, 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 카바페넴 기반 항생제의 개발 증가는 향후 시장 성장을 주도할 가능성이 높습니다.

유형별 카바페넴 기반 항생제 시장 점유율 – 2021년 및 2028년

표시 기반 통찰력

표시에 따라 카바페넴 기반 항생제 시장은 세균성 수막염, 급성 골반 감염, 호흡기 감염, 복강 내 감염, 요로 감염 등으로 분류됩니다. 기타 부문은 2021년 카바페넴 기반 항생제 시장에서 가장 큰 점유율을 차지했으며, 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 추정됩니다. 박테리아 감염의 불확실성은 카바페넴 기반 항생제에 대한 수요를 촉진하며, 이는 향후 시장 성장을 주도할 것으로 예상됩니다.

유통 채널 기반 통찰력< /h3>

카바페넴계 항생제 시장은 유통채널별로 소매약국, 온라인약국, 병원약국으로 구분된다. 병원 약국 부문은 2021년 카바페넴 기반 항생제 시장에서 가장 큰 점유율을 차지했으며 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 추정됩니다.

 

신제품 출시와 같은 유기적 전략은 기업이 시장에서 제품 포트폴리오를 확장하기 위해 일반적으로 채택합니다. 또한 회사는 인수 합병, 파트너십과 같은 다양한 무기 전략을 구현했습니다. 예를 들어, 2021년 5월 Gland Pharma Limited는 Dr Reddy's Laboratories Ltd와 협력하여 주사용 Ertapenem, 1g/바이알을 출시했습니다. 이는 INVANZ(주사용 에르타페넴)의 제네릭 버전과 동등한 치료제인 1g/바이알입니다. 미국 식품의약국(USFDA)의 승인을 받았습니다.

회사 프로필

  • Pfizer Inc.
  • Savior Lifetec
  • 스미토모 다이닛폰 제약 주식회사
  • Merck & Co., Inc.
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • 대웅제약(주)
  • Iterum Therapeutics plc
  • li>
  • ACS Dobfar SpA
  • Spero Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the carbapenem-based antibiotics?

Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.

What are the driving factors for the global carbapenem-based antibiotics market across the world?

The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.

Who are the major players in market the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.

Which segment is dominating the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.

The List of Companies - Carbapenem Based Antibiotics Market

  1. Pfizer Inc.
  2. Savior Lifetec
  3. Sumitomo Dainippon Pharma Co., Ltd.
  4. Merck & Co., Inc.
  5. Gland Pharma Limited
  6. Aurobindo Pharma Ltd
  7. Daewoong Pharmaceutical Co.,Ltd,
  8. Iterum Therapeutics plc
  9. ACS Dobfar S.p.A
  10. Spero Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports